Trials / Completed
CompletedNCT02446054
A Study to Evaluate the Effect of Musashino Diabetes Diet in Type II Diabetes Mellitus Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Celio Technology Inc. · Industry
- Sex
- All
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation the change of patients' glycosylated hemoglobin (HbA1c) after 12 weeks diet control
Detailed description
In this study, we provide the delivery service of Musashino T2DM diet for 12 weeks to patients with T2DM, to evaluate the effect on glycosylated hemoglobin (HbA1c), progression and compliance during study period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Musashino T2DM diet | provide Musashino T2DM diet for 12 weeks to T2DM patients, to evaluate the effect on glycosylated hemoglobin (HbA1c), progression and compliance during study period. |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2015-09-01
- Completion
- 2015-12-01
- First posted
- 2015-05-15
- Last updated
- 2016-01-28
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT02446054. Inclusion in this directory is not an endorsement.